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The radiation response of V79 and human tumour
multicellular spheroids cell survival and growth delay
studies
C.M.L. Westl*, R.R. Sandhu2 & I.J. Stratford'
1Radiobiology Unit, Department ofPhysics and 2Radiotherapy Research Unit, Institute of Cancer Research,
Clifton Avenue, Sutton, Surrey SM2 5PX, U.K.
Summary Chinese hamster cells (V79 379A) cells from a human small cell carcinoma of the lung
(ME/MAR) and two xenografted human melanomas (HX117 and HX118) have been grown as multicellular
spheroids in vitro. The radiation response of these four cell types has been compared when grown as
spheroids (200 or 400 pm in diameter) and as single cells from disaggregated spheroids. The radiation
sensitivity of tne three human lines irradiated as single cells in air, is similar. In comparison, the V79 cells are
more radioresistant. Only the V79 and HX118 cells show a spheroid size dependent radiation response. The
radiation response of spheroids has been assayed using both cell survival and growth delay. V79, ME/MAR
and HX1 17 cells demonstrate a good correlation between the two endpoints whereas with HX 118 there
appears to be greater cell kill for a given level of growth delay. This may be because HXl 18 is efficient in the
repair of potentially lethal damage (PLD). The results support the view that extrinsic factors such as three
dimensional contact, hypoxia and repair of PLD can be important and together with the intrinsic cell
radiosensitivity will determine the radiation response of tumours.
Multicellular spheroids have many characteristics
which make them an interesting in vitro model of
small solid tumours. In radiobiological studies of
Chinese hamster V79 spheroids the importance of
repair processes (Durand & Sutherland, 1972), cell
cycle kinetics (Durand & Sutherland, 1973;
Dertinger Liucke-Hiihle, 1975), hypoxia (Sutherland
& Durand, 1973) and reoxygenation (Durand &
Sutherland, 1976) have been demonstrated. A
simplified method of spheroid production using a
static culture technique was described by Yuhas et
al. (1977). Subsequently, cells from a variety of
sources, including some of human origin, were
shown to form spheroids and grow in culture
(Yuhas et al., 1978; Haji-Karim & Carlsson, 1978;
Pourreau-Schneider & Malaise, 1981). Recently, we
undertook a study of spheroid formation by cells
from a wide variety of xenografted human tumours
(Jones et al., 1982). It was shown that there was a
heterogeneity of response between the different cell
types to a variety of chemotherapeutic drugs and
this broadly reflected the xenograft response in the
mouse.
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It has been suggested that the wide variation in
radiocurability of human tumours may be less
dependent upon the inherent radiation sensitivity of
the cells than on extrinsic factors such as hypoxia
and/or the repair of potentially lethal damage
(PLD) (Weichselbaum et al., 1982) or on other so-
called "contact effects" (Dertinger & Liicke-Hiihle,
1975; Durand, 1980). In order to provide
information which might substantiate these
suggestions we have compared the radiosensitivity
of V79 spheroids and those of spheroids derived
from two xenografted human tumours and a
human tumour cell line. These were respectively,
cells from two malignant melanomas, tumours
likely to be radiation resistant, and from a small-
cell carcinoma of the lung, generally considered to
be clinically radioresponsive. The radiation
response of 200 and 400pm spheroids has been
assayed by growth delay and cell survival and,
when appropriate, comparison has been made with
the radiation response of single cells.
Materials and methods
Cells
V79 379A (Chinese hamster cells) were routinely
grown as single cells in suspension at 37°C, in
250ml conical flasks in Eagle's minimal essential
medium (MEM) modified for suspension cultures
(Flow Laboratories Ltd.) and supplemented with
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7.5% foetal calf serum (FCS, Flow). Medium
containing cells was buffered with bicarbonate to
pH 7.4. Cells were maintained in air in
asynchronous, exponential growth at concentrations
varying between 105-106cellsml -1.
ME/MAR was derived from a metastatic small
cell lung tumour and established in vitro (Ellison et
al., 1976). Cells (2 x l05) were seeded into 50ml
tissue culture flasks in Hams F12 +15% FCS
(Gibco) in air at 37°C. Cells formed aggregates
(spheroids) and were passaged every 10 days using
0.25% trypson (Flow). Experiments were carried
out on passages 20-24 from the original tumour.
These cells were subsequently shown to form
tumours in immune-suppressed mice and, to
conform with our nomenclature, have been
designated HX124.
HX117 and HX118 were both derived from
metastatic melanomas and established as xenografts
in 1981 (Courtenay & Mills, unpublished). They
were maintained by serial passage in immune-
suppressed mice prepared as described by Steel et
al. (1978). Tumours were excised aseptically from
the mouse following cervical dislocation. The
excised tumours were washed twice in Hams F12
without serum, finely chopped using crossed
scalpels and then incubated for 30mins in a 1 in 10
dilution of filter sterilised Collagenase/Pronase/
DNAase cocktail (Brown et al., 1980). The cell
suspension was then washed twice by centrifugation
and resuspension and filtered through a 24-30pm
polyester mesh (Henry Simon, Stockport). The
present experiments were carried out on passages
7-11.
Spheroidproduction
The method of Yuhas et al. (1977) was used as the
basis for the initiation of growth of V79, HX117
and HX118 spheroids. ME/MAR were maintained
as spheroids (aggregates) as described above.
V79 spheroids 2x 104 cells in 10ml MEM+10%
FCS were seeded into 9cm bacterial petri dishes
base-coated with 1% agar/MEM and incubated at
37°C. Medium was replenished after 3 days and
thereafter daily.
HX117 and HX118 106 cells in 10ml Hams
F12+15% SBCS were seeded into dishes base
coated with 1.5% agar/Hams F12+15% SBCS
(Special Bobby Calf Serum, Gibco Ltd.). Dishes
were incubated at 37°C in 5% 02+ 5% CO2. After
5 days the medium was replenished and 2 to 5 days
later spheroids were transferred to 100ml spinner
vessels and held in 5% 02+5% CO2 at 370C.
Radiation treatment
Spheroids (200 or 400,pm diameter) were harvested
by filtration through appropriately sized polyester
mesh followed by microscopic selection. Intact
spheroids or cells from spheroids disaggregated
with 0.25% (V79, ME/MAR) or 0.05% (HX117
and HX118) trypsin were prepared for irradiation
on 5cm glass petri dishes held in Dural containers
(Cooke et al., 1976). Intact spheroids were placed
in dishes containing 2.5ml growth medium, and
maintained at 37°C prior to and during irradiation.
Single cells were also placed in dishes containing
2.5ml medium and gassed at room temperature
with either air+5% CO2 as for the spheroids, or
95% N2/5% CO2 for 1 h to render cells hypoxic.
Irradiations were done with cobalt-60 y-rays, at a
dose rate of 4.2Gymin-1. The spheroids were
assayed by cell survivial and growth delay; the
response of single cells was determined by
measurement of cell survival
Clonogenic cell survival
Immediately after radiation treatment spheroids
were disaggregated with trypsin. Single cell
suspensions were then washed by centrifugation
and resuspension, counted, diluted and plated.
V79 cells were plated onto 6cm tissue culture
dishes (Sterilin) in 2.5ml MEM+ 15% FCS and
incubated for one week at 37°C in air +5% CO2
before scoring for colony formation.
ME/MAR, HX117, HX118 - the 3 human tumour
cell lines were assayed for cell survival using
modifications of the soft agar technique described
by Courtenay (1976) and Courtenay & Mills (1978).
Details of the procedure used for ME/MAR have
been given preViously (Jones et al., 1982). For
HX117 and HX118, 1 ml of tumour cell suspension
at 5 x the required concentration, 0.5ml of a 1 in 8
dilution of August rat red blood cells (previously
heated at 44°C for 1 h) and 0.5ml of heavily
irradiated cells (105cellsml-1) were mixed with 3ml
0.5% agar/Hams F12+15% SBCS. One ml
aliquots were dispensed into test tubes (Falcon) and
incubated at 37°C in 3% 02+5% CO2 for up to 4
weeks (Courtenay, 1983). At weekly intervals
during the incubation 1 ml of medium was added to
the test tubes, at the end of the third week medium
was replaced. Colonies of >50 cells were scored.
Growth delay
Linbro 24 microwell plates were coated with 0.5%
agar/medium. After radiation treatment intact
spheroids were placed in 1 ml of growth medium in
individual wells, and incubated at 370C in 5%RADIATION AND HUMAN TUMOUR SPHEROIDS 145
02+5% CO2 (HX117, HX118) or air+5%CO2
(V79, ME/MAR). Twelve spheroids of uniform size
were selected per treatment. Two diameters at right
angles were measured using a calibrated graticule
under an inverted microscope at the time of
treatment and thereafter at 2, 3 or 4 day intervals.
Volumes were calculated using the formula for an
elipsoid and plotted against time. Medium was
replaced every 5 days for V79 spheroids and weekly
for the human tumour lines.
Results
Single cell and spheroid characteristics
Table I lists the plating efficiency, volume doubling
time, number of cells per spheroid, and average cell
diameter, for the V79 and human tumour spheroids
used in these experiments. Initial volume doubling
times ranged from 4.2 days for the slowest growing
HX1 18 to 0.76 days for the V79 spheroids. Plating
efficiencies varied from 76% for V79 to 3.1% for
HX118 spheroid cells. There was also considerable
variation in the average cell diameter of the
different cells, which affects the number of cells per
spheroid of a given size.
Cell survival
Figure 1 illustrates the response of single cells taken
from dissociated spheroids, irradiated under aerobic
or hypoxic conditions. All data points are shown in
this and subsequent figures except where there are
values from three or more experiments when error
bars are used to illustrate standard errors. Survival
curves have been computed using the multi-target
equation (Millar et al., 1978). Values ofDo, and the
oxygen enhancement ratio (OER) for each cell line
is given in Table II. The V79 cells show greater
radiation resistance than the human tumour cells,
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Figure 1 Radiation dose-log survival curves for cells
taken from dissociated spheroids and irradiated under
aerobic (0), or hypoxic (0), conditions. All data points
are shown except when three or more survival points
were obtained at a given dose, bars indicating
standard errors are then shown. In many instances e.g.
ME-MAR, the error bars lie within the dimensions of
the plotted points. When only one survival point has
been determined at a given radiation dose this is
indicated by (1).
Table II Cell survival data
Cell line DO/Gya OERb
Air N2
V79 2.01 +0.18 6.12+0.29 3.0
ME/MAR 1.27+0.30 4.10+0.43 3.2
HX117 1.67+0.30 3.05+0.29 1.8
HX118 1.28+0.12 4.27+0.16c 3.3
'All values of Do and their associated standard errors
were computed using the multitarget model.
bRatio ofDo values.
cThis value of Do was calculated by fixing the ordinate
at a value of 1 at zero dose.
Table I Spheroid characteristics
Estimated number ofcells
Initial volume doubling per spheroidb
% plating time (200pm spheroids) Cell diameter/pm
Cell line efficiency /days (200pm spheroids)a 200pm 400pm 600pgm
V79 76.0 (68-82) 0.76 (0.69-.85) 11.5 3.6 x 103 2.2 x 104 4.9 x 104
ME/MAR 33.0 (10-69) 3.6 (3.2-4.3) 10.5 3.5 x 103 2.7 x 104 1.6 x 105
HX117 4.1 (2.3-7) 2.9 (2.0-4.2) 18.0 2.4x 102 4.2x 103
HX118 3.1 (1.5-5) 4.2 (3.7-8) 20.0 2.0x 102 4.0x 103
Figures in parenthesis indicate the range of values obtained.
aSizes of cells from trypsinized spheroids were determined using a Coulter Channalizer and those sizes given
are for the majority of cells within each spheroid population.
blOO spheroids of appropriate size were selected, trypsinized and the number of cells in suspension counted
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each of which show similar values of Do in air.
Under hypoxic conditions the human tumour cells
do not show similar radiation sensitivity and this is
reflected by a variation in OER from 1.8 for the
melanoma HX117 up to 3.3 for HX118.
Survival of cells from V79 spheroids irradiated in
air is shown in Figure 2. Dashed lines are
transposed from Figure 1 for comparison and show
that there is little difference in response of 200pm
spheroids from that seen for single cells. However,
for 400pm spheroids there is a radiation resistant
tail to the survival curve. This is likely to be due to
the presence of a radiation resistant hypoxic
fraction of cells in V79 spheroids of this size
0
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Figure 2 Radiation dose log-survival curves for
clonogenic Chinese hamster V79 cells in multicellular
spheroids irradiated when at 200pm (0) or 400pm
(0, *) diameter. Prior to irradiation spheroids were
grown in spinner culture (-) or under static
conditions (0, 0).' Dashed lines indicate the survival
curves for cell suspensions irradiated under aerobic or
hypoxic conditions (Figure 1).
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(Sutherland & Durand, 1973). Generally, V79
spheroids are cultivated in static culture and the
radiation response of these spheroids are shown as
the circles in Figure 2. We have, for comparison,
grown V79-379A cells as spheroids in spinner
culture. The radiation response of 400pm V79
spheroids grown in this way is also shown in Figure
2. The data suggest that these culture conditions do
not affect response when the irradiation is carried
out under identical conditions (cf. Durand, 1980).
The survival of cells from irradiated human
tumour spheroids is shown in Figure 3. In each
case, the radiation response of cells taken from
200pm spheroids is similar to that of single cells in
air. ME/MAR and HXl 17 spheroids show similar
responses when irradiated at 200 or 400,pm
diameter, whereas, the radiation response of HX118
spheroids shows a clear size dependence. This may
indicate the presence of a large hypoxic fraction
and/or a contact effect in this cell type.
Growth delay
Data from individual sets of experiments showing
growth of V79 spheroids (200, 400 and 600 m) and
human tumour spheroids (200 and 400 um) after
various doses of radiation are shown in Figures 4
and 5 respectively. In these figures the data are
normalized to the initial treatment volume. The
growth curves for V79, ME/MAR and HX117
spheroids generally show some delay in growth
after irradiation, followed by an increase in
spheroid volume at a rate similar to untreated
controls. In contrast, HX118 spheroids do not
appear to show this characteristic; instead, beyond
the first week after irradiation, a decreased growth
rate relative to control is observed.
Growth of V79 spheroids (Figure 4) shows a
clear size-dependent effect after irradiation with
20Gy. Spheroids (200jim) cease to grow and break
Dose (Gy)
Figure 3 Radiation dose log-survival curves for clonogenic human tumour cells in multicellular spheroids
irradiated when at 200pm (0) or 400pm (0) diameter. Dashed lines indicate the survival curves for cell
suspensions irradiated under aerobic conditions (Figure 1).
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Figure 4 Growth curves for various sizes of V79 spheroid irradiated with zero (0), 5 (LI), 10 (A), 15 (0) or
20Gy (O) y-rays. Points show the mean volume change for groups of 12 spheroids and bars indicate standard
errors. (Omitted from some of the data for clarity.)
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Figure 5 Growth curves for irradiated human tumour spheroids. Left panels 200pm diameter, right panels
400pm diameter. ME-MAR; zero (0), 2 (O), 3 (A), 4 (0) or 5Gy (O:'). HXl17 and HX118; zero (0), 2
(E), 4 (A), 6 (0), or 8Gy (O). Points show the mean volume change for groups of 12 spheroids and bars
indicate s.e. In some instances bars are omitted, either for clarity or because errors lie within the dimensions
of the plotted points.
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up after this radiation dose such that it was not
possible to measure regrowth. In contrast cells from
400,pm spheroids can survive and act as foci for
regrowth.
Inspection of Figure 5 gives little indication of a
size dependent response for regrowth of ME/MAR
spheroids after irradiation, which is consistent with
the cell survival data for these spheroids. HX117
spheroids also show no size dependent effect (see
Figure 6). However, this is not so apparent from
the examples in Figure 5 due to the fact that the
control growth rates span the range of those
obtained in our experiments.
Figure 5 also shows that there is regrowth from
both 200 and 400pm HX118 spheroids after
radiation doses up to 8 Gy. At the highest dose
given to the 200pm spheroids (200 cells per
spheroid), no growth would be expected if all the
cells were aerobic as evidenced by the cell survival
assay (Figure 3). This may suggest that cells in
intact HX118 spheroids can recover from radiation
damage that otherwise would be lethal if the
spheroids were disaggregated immediately after
treatment and cells plated to assess survival.
From the data in Figures 4 and 5 and from many
additional experiments with each cell type at each
spheroid size, we have determined the Specific
Growth Delay (SGD) as a function of radiation
dose, where
Ttreated -Tcontrol
SGD = TDcontrol
and where T is the time taken to reach 4 x the
initial treatment volume and TD is the initial
0
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Figure 6 Plot of specific Growth Delay versus
radiation doses for V79, circles and crosses; ME-
MAR, triangles; HX117, squares and HX118
diamonds. Open symbols 200jum, closed symbols
400,um and crosses 600,um spheroids. Error bars are
omitted for clarity, they are as shown in Figure 8.
volume doubling time (Bailey et al., 1980; Kopper
& Steel, 1975). These results are shown in Figure 6.
A size dependence is apparent for the V79
spheroids, whereas this is not the case for the
human tumour spheroids. ME/MAR and HX117
respond similarly at both 200 and 400pm diameter,
which is consistent with their response when
assayed by cell survival. In contrast, HX118
spheroids appear more resistant than the other
human tumour spheroids when assayed by growth
delay. This difference could be due to the repair of
PLD in HX118 spheroids.
In order to investigate this possibility experiments
were carried out where spheroids were given a
range of radiation doses then assayed for cell
survival either immediately (Figures 2 and 3) or
24h after treatment. Figure 7 shows a plot of
Recovery Ratio (the ratio of surviving fraction at
24h relative to that at 0h) as a function of
radiation dose for HX1 17 and HX118 spheroids. It
is clear that for HX118 spheroids cell survival is
increased when the assay is carried out 24h after
treatment. This is not the case for HX117
spheroids. Therefore, repair of PLD is a feature of
HX1 18 spheroids and this may contribute to the
observation that these spheroids are more resistant
when assayed by growth delay.
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Figure 7 Plot of Recovery Ratio (surviving fraction
assayed 24h after treatment compared to that
obtained at zero hours) as a function of radiation dose
in H117 (squares) and HX118 spheroids (diamonds).
Errors are derived from 4 separate experiments.
Discussion
In this work we have set out to determine whether
factors other than the intrinsic cellularRADIATION AND HUMAN TUMOUR SPHEROIDS
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Figure 8 Plot of specific Growth Delay versus surviving fraction for irradiated V79 and human tumour
spheroids. Left panel=circles, V79; triangles, ME-MAR and squares, HX117 cells. Right panel: diamonds,
HX118 cells; the dashed line is taken from the left panel for comparison. Open symbols are for data obtained
with 200pm, closed symbols for 400,um and crosses for 600pm diameter spheroids. Bars indicate s.e. of data
from two or more experiments carried out at a given radiation dose. When bars are not shown they lie within
the dimensions of the plotted points.
radiosensitivity can contribute to the response of
multicellular spheroids to radiation. To do this
spheroid response has been assessed using the end-
points of growth delay and cell survival. Both
assays reveal a size dependent response for the V79
spheroids, but not for the 200 and 400 im
ME/MAR or HX117 spheroids at the radiation
doses tested. While for HX118 a dependence upon
size was noted in the cell survival assay but not in
the growth delay assay. The radiation sensitivity of
each of the human tumour cell types is similar,
when assayed by the survival of single cells in air.
However, HX118 spheroids appear considerably
more resistant than ME/MAR and HX117
spheroids when radiation response is assayed by
growth delay.
The characteristic growth pattern of spheroids
after cytotoxic treatment is for some delay followed
by regrowth at a rate similar to untreated controls
(see e.g. Twentyman (1980), Yuhas et al., (1978)).
This pattern is observed with the V79, ME/MAR
and HX117 spheroids but not the HX118
spheroids. This difference in response, for which we
have no explanation, could alter values of SGD for
HX118 depending upon what increase in volume is
used to determine growth delay times. We have
calculated SGD at values other than 4 x the initial
treatment volume and when comparison is made
between the human tumour cell types our
conclusion remains the same i.e. HX118 spheroids
are more resistant than the other human tumour
spheroids when the assay is by growth delay.
The difference between HXl 18 and the other
spheroid types can be further emphasized when the
two assays of spheroid response are compared as in
Figure 8. The left-hand panel shows all our data
for the V79, ME/MAR and HXl 17 spheroids.
Irrespective of the type of the spheroids or their size
there is an apparent relationship between log cell
survival and specific growth delay. A linear
regression analysis gives values of 0.28 and 0.46 for
the slope and intercept respectively with a
correlation coefficient c=0.94. Theoretically, if cell
survival and growth delay are well correlated then a
decade of cell kill requires 3.32 doublings of the
surviving cells for growth to the original treatment
volume. Our results in Figure 8 for V79, ME/MAR
and HX117 spheroids are in reasonable agreement
with this theoretical prediction (1/slope=3.6, cf.
theoretical value of 3.3). This indicates that both
the end-points used to assess radiation response are
equivalent in these cell types. A similar conclusion
was reached by Pourreau-Schneider & Malaise
(1981) when comparing cell survival and LD50 as
assays of radiation response of human myeloma
Nal spheroids. However, it would be expected
that the intercept in figure 8 should be unity. This
is not the case and it may be due to the fact that
cells suffer an increasing amount of cell cycle delay
as a function of radiation dose. This would lead to
a non-linear relationship between SGD and cell
survival, with a tendency for values of SGD to be
larger than would be predicted at lower surviving
fractions.
The data for HX1 18 shown in the right hand
panel to figure 8 do not appear to follow the same
trend as that seen for the other spheroids; a greater
degree of cell killing is observed for a given specific
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growth delay. Such a trend has been demonstrated
previously by Twentyman (1980) with EMT6
spheroids treated with a number of cytotoxic
agents. In this chemotherapy study it was shown
that considerable amounts of PLD repair occurred
up to 24h after treatment, which meant an
artificially low level of cell survival was seen when
spheroids were assayed immediately after treatment.
It is known that repair of PLD can occur after
irradiation of melanoma cells in vitro and in vivo
(Chavandra et al., 1981; Guichard & Melaise, 1982;
Weichselbaum et al., 1982). We have carried out
experiments with HX1 18 spheroids of 200 to
400pum diameter, where survival has been assayed
immediately or 24h after treatment. At the latter
time a substantial reduction in cell kill has been
observed. However, it is unlikely that repair of
PLD alone can be sufficient to explain all our
results with HX118, e.g. the difference in cell
survival assay for 200 and 400 im spheroids
(Sandhu, unpublished results). It is possible there is
a contribution to the overall response of HX118
spheroids due to the "contact effect" similar to that
described by Dertinger et al. (1982).
The inherent radiation sensitivity of aerobic cells
may be used as a guide to the radiation response of
spheroids' However, in assessing the overall
response of spheroids and indeed tumours, the
possible contribution of hypoxia, PLD repair and
other "contact effects" must be considered. Our
results suggest that the use of multicellular
spheroids may allow some of these effects to be
rationalized.
In conclusion V79 spheroids and spheroids
derived from human tumour xenografts can have
their response to radiation assayed by cell survival
or regrowth delay. When comparison can be made
with the xenograft it should be possible to separate
out any contributory host effects. Thus the
spheroid should prove a valuable model for
assessing the radiation response of human tumours.
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